Avelo AG
PrivateLast Round
Grant
Dec 14, 2023
Total Funding Raised
$4.17M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Avelo AG operates in Healthcare & Life Sciences and is based in Schlieren. Its latest recorded funding round was a Grant round in December 2023.
Avelo AG is a healthcare technology company that develops non-invasive breath sampling devices for the diagnosis of tuberculosis and lower respiratory tract infections.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avelo AG Comparables
Compare Avelo AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Respiratory Research, Inc. | 78% | |
| Breath Diagnostics | 78% | |
| Deep Breath Intelligence | 68% |
For institutional investors. Book with your work email.
Avelo AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 14, 2023 | ||||
| Grant | Oct 26, 2023 | ||||
| Seed | Sep 20, 2022 | ||||
| Grant | Jun 22, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Avelo AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arve Capital | Seed |
| Eurostars SME programme | Grant |
| Innosuisse | Grant |
| Venture Kick | Grant |
| OCCIDENT | Seed |
| Privilège Ventures | Seed |
| Zurcher Kantonalbank | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 162% MoM.
- May 18, 2026
Monthly visitors increased 50% MoM.
For institutional investors. Book with your work email.
Avelo AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Avelo AG's valuation, stock price, and market status.
Is Avelo AG a public or private company?
Avelo AG is a private company.
What is the current stock price of Avelo AG?
Avelo AG is a private company, so its shares have no public market price. Caplight tracks Avelo AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avelo AG worth (valuation)?
Valuation information for Avelo AG is not publicly available.
Can I buy Avelo AG stock?
Avelo AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avelo AG's last funding round?
Avelo AG's most recent funding round was Grant on December 14, 2023.
Who are the main investors in Avelo AG?
Key investors in Avelo AG include OCCIDENT.
Will Avelo AG IPO soon?
No public IPO plans have been announced for Avelo AG.
How can I track Avelo AG secondary market activity?
Caplight tracks bids, offers, and trades in Avelo AG's shares on secondary markets.